J 2015

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

NOETZLI, Leila; Richard W. LO; Alisa B. LEE-SHERICK; Michael CALLAGHAN; Patrizia NORIS et al.

Základní údaje

Originální název

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

Autoři

NOETZLI, Leila; Richard W. LO; Alisa B. LEE-SHERICK; Michael CALLAGHAN; Patrizia NORIS; Anna SAVOIA; Madhvi RAJPURKAR; Kenneth JONES; Katherine GOWAN; Carlo L. BALDUINI; Alessandro PECCI; Chiara GNAN; Daniela DE ROCCO; Michael DOUBEK; Ling LI; Lily LU; Richard LEUNG; Carolina LANDOLT-MARTICORENA; Stephen HUNGER; Paula HELLER; Arthur GUTIERREZ-HARTMANN; Xiayuan LIANG; Fred G. PLUTHERO; Jesse W. ROWLEY; Andrew S. WEYRICH; Walter H.A. KAHR; Christopher C. PORTER a Paola DI JORGE

Vydání

Nature genetics, New York, Nature Publishing Group, 2015, 1061-4036

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 31.616

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/15:00083395

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

acute lymphoblastic leukemia; alternative RNA splicing; amino acid substitution;

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 15. 7. 2015 17:19, Soňa Böhmová

Anotace

V originále

Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia(1,2). We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.